Each Division << National Cancer Center Research Institute
About National Cancer Center to HOME to National Cancer Center Research Institute
font size| large | normal | small |
spacer
HOME > National Cancer Center Research Institute > Publication & Reports > List of Papers Published This Month

List of Papers Published This Month


Group for Cancer Development
1. Division of Cancer Development System
Group for Research of Molecular Functions and Targets
2. Division of Molecular and Cellular Medicine
Group for Development of Molecular Diagnostics and Individualized Therapy
3. Division of Pharmacoproteomics
4. Division of Cancer Genomics
Group for Translational Research
5. Division of Cancer Pathophysiology
Project Group
6. Division of Brain Tumor Translational Research

1. Division of Cancer Development System

1. Ochiai M, Hippo Y, Izumiya M, Watanabe M, Nakagama H. Newly defined aberrant crypt foci as a marker for dysplasia in the rat colon. Cancer Sci, 2014

2. Division of Molecular and Cellular Medicine

2. Chen AK, Sengupta P, Waki K, Van Engelenburg SB, Ochiya T, Ablan SD, Freed EO, Lippincott-Schwartz J. MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production. Proc Natl Acad Sci U S A, 111:E2676-E2683, 2014

3. Ono M, Kosaka N, Tominaga N, Yoshioka Y, Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K, Ochiya T. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal, 7:ra63, 2014

4. Seino S, Takeshita F, Asari A, Masuda Y, Kunou M, Ochiya T. No influence of exogenous hyaluronan on the behavior of human cancer cells or endothelial cell capillary formation. J Food Sci, 79:T1469-T1475, 2014

3. Division of Pharmacoproteomics

5. Hosoya N, Sakumoto M, Tomita Y, Kondo T. Approach to spot overlapping problem in 2D-PAGE revealed clinical and functional significance of RKIP and MnSOD in renal cell carcinoma. EuPA Open Proteomics, 4:129-139, 2014

6. Kondo T. Inconvenient truth: cancer biomarker development by using proteomics. Biochim Biophys Acta, 1844:861-865, 2014

7. Kondoa T, Kawai A. A proteomics approach for the development of sarcoma biomarkers. EuPA Open Proteomics, 4:121-128, 2014

8. Kubota D, Yoshida A, Kawai A, Kondo T. Proteomics identified overexpression of SET oncogene product and possible therapeutic utility of protein phosphatase 2A in alveolar soft part sarcoma. J Proteome Res, 2014

9. Mukaihara K, Kubota D, Yoshida A, Asano N, Suehara Y, Kaneko K, Kawai A, Kondo T. Proteomic profile of epithelioid sarcoma. J Proteomics Bioinform, 7:158-165, 2014

10. Tani Y, Tajima T, Kawai A, Unuma Y, Kinoshita H, Kondo T. Evaluation of a novel automated machine, the auto2D, for two-dimensional gel electrophoresis. J Proteomics Bioinform, 7:108-111, 2014

4. Division of Cancer Genomics

11. Shibata T, Aburatani H. Exploration of liver cancer genomes. Nat Rev Gastroenterol Hepatol, 11:340-349, 2014

12. Sugita S, Arai Y, Tonooka A, Hama N, Totoki Y, Fujii T, Aoyama T, Asanuma H, Tsukahara T, Kaya M, Shibata T, Hasegawa T. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of ewing-like sarcoma. Am J Surg Pathol, 2014

13. Takahashi H, Ojima H, Shimizu H, Furuse J, Furukawa H, Shibata T. Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma. Jpn J Clin Oncol, 44:570-578, 2014

5. Division of Cancer Pathophysiology

14. Nagamura Y, Terawaki K, Uezono Y, Tsukada T. Enhancement of catecholamine release from PC12 cells by the traditional Japanese medicine, rikkunshito. BMC Complement Altern Med, 14:256, 2014

6. Division of Brain Tumor Translational Research

15. Arita H, Narita Y, Yoshida A, Hashimoto N, Yoshimine T, Ichimura K. IDH1/2 mutation detection in gliomas. Brain Tumor Pathol, 2014

to this page top